Abstract CT219: Neoadjuvant letrozole and palbociclib in stage II-IIIB HR[+]/HER2[-] breast cancer with Oncotype DX Recurrence Score®(RS) 18-25 or 26-100. Analysis of RS changes at surgery (DxCARTES trial)

Author(s):  
Antonio Llombart Cussac ◽  
José Pérez-García ◽  
Ángel Guerrero ◽  
Begoña Bermejo ◽  
Miguel Gil ◽  
...  
2018 ◽  
Vol 29 ◽  
pp. viii68
Author(s):  
F. Namuche ◽  
R.E. Ruiz ◽  
Z.D. Morante Cruz ◽  
D. Urrunaga ◽  
A. Aguilar Cartagena ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12059-e12059
Author(s):  
Patricia Novas ◽  
Elena Galve Calvo ◽  
Maria Angeles Sala Gonzalez ◽  
Juan Fernando Arango arteaga ◽  
Borja Lopez De San Vicente ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document